Since the 1990s, more than two dozen drugs have been approved to treat multiple sclerosis. But a question looms: For older adults — who are less likely to suffer the disease’s hallmark flare-ups, and more likely to experience troublesome side effects from the drugs themselves — does there come a time to quit?
↧